Sun Pharma Advanced Research Co (NSE:SPARC) Total Assets : ₹3,355.3 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Total Assets?

Sun Pharma Advanced Research Co's Total Assets for the quarter that ended in Mar. 2025 was ₹3,355.3 Mil.

During the past 12 months, Sun Pharma Advanced Research Co's average Total Assets Growth Rate was -7.50% per year. During the past 3 years, the average Total Assets Growth Rate was 7.40% per year. During the past 5 years, the average Total Assets Growth Rate was 9.40% per year. During the past 10 years, the average Total Assets Growth Rate was 10.80% per year.

During the past 13 years, Sun Pharma Advanced Research Co's highest 3-Year average Total Assets Growth Rate was 36.20%. The lowest was 2.10%. And the median was 10.25%.

Total Assets is connected with ROA %. Sun Pharma Advanced Research Co's annualized ROA % for the quarter that ended in Mar. 2025 was -71.25%. Total Assets is also linked to Revenue through Asset Turnover. Sun Pharma Advanced Research Co's Asset Turnover for the quarter that ended in Mar. 2025 was 0.08.

Sun Pharma Advanced Research Co Total Assets Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Total Assets Chart

Sun Pharma Advanced Research Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Assets

Get a 7-Day Free Trial

2,296.90

2,800.83

8,301.26

5,150.42

3,355.30

Sun Pharma Advanced Research Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Assets	Get a 7-Day Free Trial															5,150.42	-	-	-	3,355.30

Sun Pharma Advanced Research Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sun Pharma Advanced Research Co's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets	=	Total Equity (A: Mar. 2025 )	+	Total Liabilities (A: Mar. 2025 )
	=	-2169.5	+	5524.8
	=	3,355.3

Sun Pharma Advanced Research Co's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2025 )	+	Total Liabilities (Q: Mar. 2025 )
	=	-2169.5	+	5524.8
	=	3,355.3

Sun Pharma Advanced Research Co (NSE:SPARC) Total Assets Explanation

Total Assets is connected with ROA %.

Sun Pharma Advanced Research Co's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %	=	Net Income (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
	=	-2390.8	/	( (0	+	3355.3)	/ 1 )
	=	-2390.8	/	3355.3
	=	-71.25 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sun Pharma Advanced Research Co's Asset Turnover for the quarter that ended in Mar. 2025 is

	Asset Turnover
=	Revenue (Q: Mar. 2025 )	/	( (Total Assets (Q: Dec. 2024 )	+	Total Assets (Q: Mar. 2025 ))	/ count )
=	271.9	/	( (0	+	3355.3)	/ 1 )
=	271.9	/	3355.3
=	0.08

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sun Pharma Advanced Research Co Total Assets Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Total Assets

Traded in Other Exchanges

532872:India

Address

Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093

Website

https://www.sparc.life

Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines